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Background: Bacterial resistance development is one of the most urgent problems in healthcare worldwide. In
Europe, dentistry accounts for a comparatively high amount of antibiotic prescriptions. In light of increasing levels
of bacterial resistance, this development is alarming. So far, very few interventional studies have been performed,
and further research is urgently needed. By means of a complex educational intervention, the DREAM trial aims at
optimising antibiotic prescribing behaviour of general dentists in Germany.
Method: This is a cluster-randomised controlled trial, where each cluster consists of one dental practice and
all of its patients in a defined period. Participants are general dentists practicing in the German region of
Mecklenburg-Western Pomerania. Randomisation takes place after baseline data collection (6 months) and will be
stratified by the antibiotic prescribing rates of the participating dental practices. Dentists randomised into the
intervention group will participate in a complex small group educational seminar that aims at: increasing
knowledge on bacterial resistance, pharmacology, and prophylaxis of infectious endocarditis; increasing awareness
of dentist-patient communication using video-taped vignettes of dentist-patient communication on antibiotic
treatment; improving collaboration between general dentists, general practitioners, and practice-based cardiologists
on the necessity of antibiotic prophylaxis; enhancing awareness of the dentists’ own prescribing habits by
providing antibiotic prescribing feedback; and increasing patient knowledge on antibiotic treatment by providing
patient-centred information material on antibiotic prophylaxis of endocarditis. The dentists randomised into the
control group will not receive any educational programme and provide care as usual. Primary outcome is the
overall antibiotic prescribing rate measured at T1 (period of six months after intervention). In a subgroup of adult
patients affected by odontogenic infections, microbiological analyses for antibiotic resistance of oral streptococci
are performed.
Discussion: Major aim of the study is to improve the process of decision making with regard to antibiotic
prescribing. The approach is simple to implement and might be used rapidly in graduate and post-graduate
medical education. We expect the results of this trial to have a major impact on antibiotic prescription strategies
and practices in Germany.
Trial registration: Current Controlled Trials ISRCTN09576376
Keywords: Dentistry, Public health dentistry, Dental care for chronically ill, Anti-bacterial agents, Antibiotic
prophylaxis, Health communication, Drug resistance* Correspondence: christin.loeffler@med.uni-rostock.de
1Institute of General Practice, Rostock University Medical Center, Postfach
100888, 18055 Rostock, Germany
Full list of author information is available at the end of the article
© 2014 Löffler et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Löffler et al. Implementation Science 2014, 9:27 Page 2 of 6
http://www.implementationscience.com/content/9/1/27Background
Rising levels of bacterial resistance are one of the most ur-
gent problems in healthcare worldwide. The overuse and
the misuse of antibiotics are the basic reasons for this de-
velopment. Studies consistently confirm the association
between antimicrobial consumption and bacterial resist-
ance [1]. As a consequence, in order to reduce and slow
down the global threat of bacterial resistance develop-
ment, it is very important to reduce the inappropriate use
of antibiotics. Antimicrobial drugs should be reserved to
patients who actually benefit from the treatment.
Apart from this severe global development, at the indi-
vidual level, treatment with antibiotics correlates with
drug-related adverse reactions, such as diarrhea or allergic
reactions. Especially, if antibiotics are not indicated, these
reactions outweigh any benefit of the treatment [2].
Prescribing non-indicated antibiotics also has an im-
pact on healthcare expenditures. Both unnecessary con-
sumption of antibiotics and treatment of preventable
drug-related adverse reactions, including hospital stays,
put a huge financial burden on national healthcare sys-
tems. Optimising the use of antibiotics will decrease this
burden [3].
Data on outpatient antibiotic use show that since 1997
daily defined doses per 1,000 inhabitants per day (DID)
have increased in Europe. At the same time, prescrip-
tions of broad spectrum antibiotics have become more
common, while narrow spectrum antibiotics have been
used less [4,5]. This development is fostering further bac-
terial resistance. With 7% of all antibiotics used in primary
care, dentistry accounts for a comparatively high amount
of antibiotic prescriptions [6]. Studies indicate a non-
conforming use of antibiotics as well as a suboptimal
choice of antimicrobial substances as far as guideline rec-
ommendations are concerned [7,8]. In light of increasing
levels of resistance, this development is alarming [6].
As to general dentistry in Germany, little data exists.
However, comparing absolute numbers of antibiotic pre-
scriptions in primary care, dentists are fourth, following
general practitioners, internal specialists, and pediatri-
cians [9]. Data of German statutory health insurances on
the year 2010 show that, on average, dentists prescribed
two antibiotics per week. Interestingly, in derogation from
national and international guidelines, German general
dentists seem to favor clindamycin over preferably recom-
mended substances [10]. A study performed in northern
Germany and based on postal questionnaires shows simi-
lar results [11].
Optimising antibiotic prescribing in general dentistry
might contribute to decreasing levels of antibiotic resist-
ance development and thereby increase the quality of
healthcare provision in general. In the past, several inter-
ventional randomised controlled trials (RCTs) from other
medical fields were successful in optimising antibioticprescribing. Most of these studies focused on respiratory
tract infections, the disease that causes most antibiotic
misuse and overuse in primary care. Results show that
complex interventions that aim at changing behaviour ra-
ther than just providing information are most efficient
[1,12-14].
Concerning dentistry, very few interventional studies
have been performed so far. Palmer et al., for example,
collected data of antibiotic prescribing among general
dentists six weeks before and after an audit that included
educational components and the provision of guidelines.
Antibiotic prescriptions decreased by 42.5%. Above that,
guideline conformity could be improved [15]. Despite
the very promising results, the study lacked a long-term
follow-up. In a three-armed RCT performed by Seager
et al., the efficiency of educational outreach visits was
compared to the provision of information material by
mail in an intervention group and to no intervention in
a control group. The educational outreach visits were
successful in reducing prescribing rates significantly and
also improved prescribing appropriateness [16]. In the
field of dentistry, where a high potential for reducing
non-indicated antibiotics exists, further research is ur-
gently needed.
To investigate the underlying reasons for inadequate
antibiotic treatment in German general dentistry, within
the DREAM trial we performed extensive qualitative re-
search. Narrative in-depth interviews with dentists re-
vealed areas and situations of non-indicated antibiotic
prescribing. These include treatment of patients during
emergency services or shortly before weekends or holi-
days when, due to a lack of time and/or follow-up, den-
tists were inclined to prescribe antibiotics. Moreover, the
treatment of patients suffering from multimorbidity was
perceived as a challenge. Both the lack of medical know-
ledge on cardiac impairments and the fear of judicial
consequences induced dentists to prescribe antibiotics
for safety reasons. Based on these results, approaches to
solve these challenging situations were developed. Espe-
cially with regard to their acceptability and practicability,
these approaches were discussed extensively among den-
tists by means of focus group discussions. The results
contributed significantly to the development of the com-
plex intervention.
Objectives
By means of a complex educational intervention, the
cluster-randomised controlled DREAM trial aims at
optimising antibiotic-prescribing behaviour of general
dentists in Germany. The complex educational interven-
tion is based on narrative in-depth interviews and focus
group discussions with dentists and includes transfer of
relevant knowledge, dentist-patient communication, im-
proved collaboration with physicians from other fields,
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The trial will test the efficiency of the intervention. In
addition, the study contains a subset of microbiological
analyses on antibiotic resistance among a subgroup of
patients affected by odontogenic infections.Methods
Trial design
A cluster-randomised controlled trial (cRCT) will be per-
formed. Clusters are employed to avoid contamination
between the intervention and the control group. Each
cluster will consist of one general dentist practice and all
of its patients during a defined period. Prior to randomisa-
tion, baseline data will be collected over a period of six
months (T0) to adjust for inter-cluster imbalances of anti-
biotic prescribing. After randomisation, the intervention
takes place which is followed by two more six-month pe-
riods of collecting antibiotic prescribing data (T1 and T2).Participants
General dentists with their practices in the German re-
gion of Mecklenburg-Western Pomerania are eligible for
participation in the trial. Given their highly selective
group of patients, dentists with sub-specializations will
not be included. Among the participating dentists, anti-
biotic prescribing data of all patients will be collected.Recruitment
All general dentists with a practice in and around 150
kilometers of Rostock (n = 665), the largest city of
Mecklenburg-Western Pomerania, will receive postal in-
vitations to take part in the study. These invitations will
be sent out in waves and will be based on a random
sample of eligible dentists. Participating dentists will
receive case payments to compensate for time and effort.
The payments are identical in the intervention and the
control group. Trained study assistants take care of the en-
rolment process. Participating dentists provide informed
consent before baseline data collection and randomization.Randomisation
Cluster-randomisation takes place after baseline data
collection. Concealment of allocation is preserved. Ran-
domisation will be stratified by the antibiotic prescribing
rates of the participating dental practices and will be
performed by a statistician; this will avoid imbalances
between the intervention and the control group.Blinding
Within the DREAM trial, it will not be possible to blind
dentists, study personnel, and statisticians.Intervention
After randomisation, dentists of the intervention group
will participate in a four-hour, small-group intervention
seminar. The complex educational seminar is based on a
review of the literature and on own extensive qualitative
research. The seminar addresses the most challenging
situations in the decision-making relating to antibiotic
prescribing in general dentistry. It includes condensed
transfer of relevant knowledge on bacterial resistance,
pharmacology, and prophylaxis of infectious endocardi-
tis; in-depth discussion on dentist-patient communica-
tion using three video-taped examples of poor, good, and
elaborated dentist-patient communication on antibiotic
treatment—the discussion particularly aims at elaborating
strategies to satisfy dentists’ and patients’ needs for safety
without prescribing non-indicated antibiotics; improved
collaboration between dentists, general practitioners, and
practice-based cardiologists by means of a standard fax
form to agree upon the need for an antibiotic prophylaxis
of endocarditis; antibiotic prescribing feedback that will be
provided every six months, and will enhance dentists’
awareness of their own prescribing habits compared to
those of their colleagues; and patient-centred information
material to be used in the dentists’ practices. The informa-
tion on the necessity to use or not use an antibiotic
prophylaxis of endocarditis shall increase patients’ know-
ledge on antibiotic treatment.
Control group
During the trial, the dentists of the control group receive
neither the seminar nor the information material. They
will provide care as usual. After the trial, the dentists of
the control group will be invited to take part in the
seminar.
Outcomes
Primary outcome is the overall antibiotic prescribing rate
of the intervention group and the control group measured
at T1, thus measured in the interval between months one
to six after intervention. A number of secondary outcomes
will be analyzed for the subgroup of patients suffering
from odontogenic infections (see below).
Sample size
Data from Northern Germany shows that about 6% of
all patients cared for in general dentistry receive antibi-
otics [11]. A relative reduction of 20% is perceived as
both clinically relevant and attainable. For comparison,
the previous CHANGE cRCT on antibiotic prescribing
in German primary care reached a relative reduction of
40% [14]. The estimated intra-class correlation coeffi-
cient (ICC) of the prior CHANGE trial was employed
for sample size calculation in this trial. In a RCT rando-
mising at patient level and aiming at a reduction of
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tion of 20%) about 5,750 patients per group are necessary
(power = 80%, level of significance (two-sided) α = 5%).
Using an ICC of 0.2 and a cluster size of 1,000 patients
the sample size needs to be adjusted with an average de-
sign factor of 4. Thus a total sample size of 46,000 patients
in 46 dental practices is necessary for the trial. Assuming
a dropout rate of 20% initially, 58 practices need to be re-
cruited for baseline (see Figure 1).
Study on antibiotic resistance of oral streptococci
In a subgroup of adult patients suffering from odonto-
genic infections, microbiological analyses on antibiotic
resistance of oral streptococci are conducted. Intraoral
swabs from the buccal mucosa will be collected of these
study patients at three points in time: at the first con-
sultation due to an odontogenic infection (T0), after two
weeks (T1), and after six months (T2). The swabs will be
transported at room temperature to the accredited diag-
nostic laboratory within two hours. There, the swabs will
be streaked onto sheep blood agar plates. After 48 hours
of incubation under a CO2-enriched atmosphere, samples
from every morphologic type of alpha-hemolytic coloniesFigure 1 Flow chart of the DREAM trial.will be gained for species identification and for determin-
ation of the antibiotic resistance profile. For each patient,
the temporal changes in present oral streptococcal species
and antibiotic resistance profiles will be recorded.
In the context of the overall cRCT, objective information
about antibiotic resistance development will be correlated
to antibiotic prescribing behaviour of dental care practices.
This information will be communicated to dentists (via
feedback) to enhance positive competition. For this sub-
group, we intend to include a total number of 500 patients
suffering from odontogenic infections. Among these pa-
tients, several secondary outcomes will be assessed. These
include severity of the infection (judged by the dentist),
pain severity, duration of therapy, re-consultation rate, ad-
verse drug events (with reference to antibiotics), complica-
tions, and antibiotic resistance developments.
Data collection, completeness, and quality
Data collection will be based on practice software. In
Germany, dentists make use of a large variety of soft-
ware packages. Trained study assistants will visit the par-
ticipating practices regularly to collect data and to verify
data quality by comparing antibiotic prescriptions and
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collection, a second study assistant will check the data
file for completeness and correctness.Statistical methods
A ‘full analysis set’ (FAS) following the principle of
intent-to-treat (ITT) will include every patient as rando-
mised. First, confirmatory analyses on efficacy variables
will be performed on the FAS patients. Because imbal-
ances are more likely among cluster-randomised trials
than among trials randomised at the patient level, vari-
ables related to dentists’ characteristics will already be
included in the primary data analysis. Initially, baseline
characteristics will be compared between groups. If sig-
nificant differences are found for variables that could po-
tentially bias the results, data analysis will be based on a
comparison of the baseline-adjusted rates of antibiotic
prescribing between the intervention and the control
group at T1 (primary outcome) and T2. The direct max-
imum likelihood approach is used as estimation proced-
ure and will provide unbiased estimated values. Analyses
for secondary endpoints will be performed in a strictly
exploratory way using analogue models.Process evaluation
After T1 a short standardised questionnaire and some
qualitative in-depth interviews with dentists of the inter-
vention group will be performed. The interviews will
focus on the usefulness and usability of the material of-
fered during the intervention seminar (e.g., standard fax
form for dentist-physician communication or patient in-
formation material) and the way dentists made use of it.
Recommendations for improvement will also be col-
lected. The interviews will be recorded, transcribed, and
analysed.Ethical approval
The study was approved by the Ethics Committee of the
Rostock University Medical Center in December 2012
(Approval-No. A 2012-0147).Study registration
The study has been registered with Current Controlled
Trials Ltd. with the reference ISRCTN09576376.Trial status
Currently (the end of 2013), the baseline data have been
collected, the participating dentists have been rando-
mised, and the dentists of the intervention group have
been trained. The T1 data collection period has started.
The data on T1 will be collected by the end of the T1
six-month period in spring 2014.Discussion
In light of rising levels of antibiotic resistance worldwide,
reducing the number of non-indicated prescriptions of
antibiotics is highly relevant. A substantial part of anti-
biotic resistance is caused in primary care [17,18]. This
has an impact on secondary healthcare as well: the in-
creasing antibiotic resistances in ambulatory care cause
a growing use of broad-spectrum antibiotics in hospitals,
a process that fosters further resistance development. Al-
though several previous studies have aimed at reducing
antibiotic prescribing in general practice and/or pediatrics
[1,12-14], so far hardly any initiative has focused on den-
tistry. This is rather surprising, because dentistry accounts
for a comparatively high amount of antibiotics and wit-
nesses increasing resistance levels among dental patho-
gens. By means of a complex educational intervention, the
DREAM trial takes up this fact and aims at optimising
antibiotic prescribing behaviour of general dentists in
Germany.
The modeling of the intervention is based on con-
cepts, such as communication training or prescribing
feedback, that have already proven their efficiency in
reducing non-indicated antibiotic prescribing in general
practice [13,14]. By performing narrative in-depth inter-
views and focus group discussions with dentists, these
concepts have been adapted to the specific setting of
dentistry. Dentist-patient communication, for example,
is subject to specific constraints: During treatment, pa-
tients usually have few possibilities to talk to their dentist.
As a consequence, gestures and facial expressions as well
as communication at the beginning and at the end of the
consultation are especially important. The intervention
seminar takes these specific conditions into account.
As to bacterial resistance development of oral strepto-
cocci, very little research exists. A study by Chardin et al.
found that, in a healthy population, treatment with amoxi-
cillin—which is commonly used in dentistry—increases
antibiotic resistance [19]. The study on antibiotic resist-
ance of oral streptococci performed in this trial will en-
hance evidence in this field. Results of these analyses will
be communicated to dentists and—by means of a positive
competition—are assumed to have a positive impact.
Conclusion
In case of positive evaluation, the intervention seminar
developed for the DREAM trial might serve as a theoret-
ically grounded and efficient concept tested for feasibility
and acceptability. Consequently, it might be integrated
into graduate and post-graduate education. Because the
intervention seminar is easy to implement and demands
relatively little time from the dentists, it might be trans-
ferred to other healthcare systems. This way, the ap-
proach might contribute to a sustainable reduction of
antibiotic prescribing in general dentistry.
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